BioPlus Acquisition Corp. (BIOS) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは R. Ross Haghighat.
BIOS を有する IPO日 2022-01-28, に上場 NASDAQ Global Market, 時価総額 $209.07M.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.